CASE DISCUSSION
Management of Hyperbilirubinemia in the Newborn Infant
Presented from India by Dr. Vishal ParmarViews
46,461
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’...
Case Summary
- Neonatal hyperbilirubinemia, defined as elevated bilirubin levels in newborns (birth to 28 days), requires careful assessment in daylight to differentiate from normal adult bilirubin values. Diagnosis involves clinical observation for jaundice starting from the head and progressing downwards, and confirmation with bilirubin level measurements. Particular attention should be given to yellowing of palms and soles, which indicates high bilirubin levels.
Speaker Profile
Dr. Vishal Parmar
Alumni- Royal College of Pediatrics & Child HealthSpecalist Paeditrician & Neonatologist, Mumbai.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.